Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-02-28
1985-12-10
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
260112R, 260112B, 424 88, 424101, 424105, 514 21, A61K 3550, A61K 3702, A61K 3900
Patent
active
045580359
ABSTRACT:
This invention relates to a material for use in preventing recurrent spontaneous abortions in women, comprising material selected from isolated syncytiotrophoblast microvillous plasma membrane and protein- and glycoprotein-containing fractions derived therefrom.
The invention also relates to a method for preventing recurrent spontaneous abortions in women, the method comprising administering to a woman a material comprising material selected from isolated syncytiotrophoblast microvillous plasma membrane and protein- and glycoprotein-containing fractions derived therefrom.
REFERENCES:
Journal of Reproductive Immunology, 2 (1980), 99-108; 1 (1979), 127-140, Ogbimi et al.
American Journal of Reproductive Immunology, 1: 246-254, (1981), Johnson et al.
Lancet, vol. II, 1981, pp. 68-70, Taylor et al.
Nature, 252, (1974), 302-303, Smith et al.
Schain Howard E.
The University of Liverpool
LandOfFree
Material for use in the treatment of spontaneous abortions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Material for use in the treatment of spontaneous abortions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Material for use in the treatment of spontaneous abortions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-58954